Description
Get Access to Selumetinib for Capsules in India
Koselugo is a kinase inhibitor used for the treatment of pediatric patients aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN).
Recommended Dosage: The recommended dosage is 25 mg/m2 orally twice daily (around every 12 hours) until the disease is progressive or unacceptable toxicity. Take koselugo capsules on an empty stomach. Avoid consuming food 2 hours prior to each dose or 1 hour after each dose. Swallow the capsules whole with water. Avoid chewing, dissolving or opening of the capsule. Do not take a missed dose unless it is beyond 6 hours until the next scheduled dose. In case vomiting occurs after capsules administration, do not take an additional dose, but carry on with the next scheduled dose.





